Merck Millipore Announces Clinical Research, Licensing And Joint Development Agreement With Sysmex Corporation
3/18/2014 9:27:41 AM
DARMSTADT, Germany--(BUSINESS WIRE)--Merck Millipore, the Life Science division of Merck, today announced a clinical research, licensing and joint development agreement with Sysmex Corporation of Japan. This collaboration will use Merck Millipore’s flow cytometry technology as a platform to accelerate the creation of new, more powerful diagnostic tools for research in blood disorders. If successful, Sysmex and Merck Millipore will collaborate on developing the imaging flow technology platform for future commercialization in hematology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by